Cytotoxic evaluation of biomechanically improved crosslinked ovine collagen on human dermal fibroblasts

Bio-Medical Materials and Engineering

Volumn 24, Issue 4, 2014, Pages 1715-1724

  Amri, M A ^a   Firdaus, M A B ^a   Fauzi, M B ^a   Chowdhury, S R ^a   Fadilah, N R ^b   Wan Hamirul, W K ^c   Reusmaazran, M Y ^c   Aminuddin, B S ^a,d   Ruszymah, B H I ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^c MALAYSIAN NUCLEAR AGENCY   (Malaysia)

^d Ampang Puteri Specialist Hospital Malaysia   (Malaysia)

Author keywords

collagen; crosslinked; human dermal fibroblast; Tissue engineering

Indexed keywords

BIOMATERIAL; COLLAGEN; CROSS LINKING REAGENT; CYANAMIDE; GLUTARALDEHYDE;

ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DERMIS; DRUG EFFECTS; FIBROBLAST; HUMAN; MATERIALS TESTING; MECHANICAL STRESS; POROSITY; SHEEP; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARBODIIMIDES; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CROSS-LINKING REAGENTS; DERMIS; FIBROBLASTS; GLUTARAL; HUMANS; MATERIALS TESTING; POROSITY; SHEEP; STRESS, MECHANICAL; TISSUE ENGINEERING;

EID: 84908666749     PISSN: 09592989     EISSN: 18783619     Source Type: Journal    
DOI: 10.3233/BME-140983     Document Type: Article

References (16)

1. M.B. Fauzi, S.R. Chowdhury, B.S. Aminuddin and B.H.I. Ruszymah, Genotoxicity and cytotoxicity of ovine collagen on human dermal fibroblasts, Saudi Medical Journal 32(12) (2011), 1311-1312.
2. H.M. Powell and S.T. Boyce, EDC cross-linking improves skin substitute strength and stability, Biomaterials 27 (2006), 5821-5827.
3. R.J. Ruderman, C.W.R. Wade, W.D. Shepard and F. Leonard, Prolong resorption of collagen sponge: vapor-phase treatment with formaldehyde, J. Biomed. Mater. Res. 7 (1973), 263-265.
4. S.D. Gorham, Collagen, in: Biomaterials, D. Byrom, ed., Stockton Press, New York, 1991, pp. 55-122.
5. A. Jayakrishnan and S.R. Jameel, Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices, Biomaterials 17 (1996), 471-484.
6. R.F. Oliver, RA. Grant, R.W. Cox and A. Cooke, Effect of aldehyde crosslinking on human dermal collagen implantin the rat, Br. J. Exp. Path. 61 (1980), 544-549.
7. E. Khor, Method for the treatment of collagenous tissue for bioprotheses, Biomaterials 18 (1997), 95-105.
8. L.L.H. Huang-Lee, D.T. Cheung and M.E. Nimni, Biochemical changes and cytotoxicity associated with degradation of polymeric glutaraldehyde derived crosslinks, J. Biomed. Mater. Res. 24 (1990), 1185-1202.
9. M.J. van Luyn, PB. van Wachem, L.O. Damink, P.J. Dijkstra, J. Feijen and P. Nieuwenhuis, Relations between in vitro cytotoxicity and crosslinked dermal sheep collagens, J. Biomed. Mater. Res. 26(8) (1992), 1091-1110.
10. L.H.H. Olde Damink, P.J. Dijkstra, M.J.A. van Luyn, PB. van Wachem, P. Nieuwenhuis and J. Feijen, Cross-linking of dermal sheep collagen using water-soluble carbodiimide, Biomaterial 17 (1995), 765-773.
11. R. Zeeman, P.J. Dijkstar, PB. van Wachem, M.J.A. van Luyn, M. Hendriks, PT. Gahalan and J. Feijen, Successive epoxy and carbodiimide cross-linking of dermal sheep collagen, Biomaterial 20 (1998), 921-931.
12. PB. van Wachem, M.J. van Luyn, L.H. Olde Damink, P.J. Dijkstra, J. Feijen and P. Nieuwenhuis, Biocompatibility and tissue regenerating capacity of cross-linked dermal sheep collagen, J. Biomed. Mater. Res. 28 (1994), 353-363.
13. N. Rajan, J. Habermehl, M.F. Cote, C.J. Doillon and D. Mantovani, Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications, Nature Protocols 6 (2006), 2753-2758.
14. A. Talebian, S.S. Kordestani, F. Dadashian, A. Rashidi, M. Montazer and M. Asghari, Study the properties of crosslinked gelatin films with glutaraldehyde, World Applied Science Journal 2(6) (2007), 575-581.
15. E. Vennat, C. Bogicevic, J.M. Fleureau and M. De Grange, Demineralized dentin 3D porosity and pore size distribution using mercury porosimetry, Dental Materials 25 (2009), 729-735.
16. W. Friess, Collagen - biomaterial for drug delivery, European Journal of Pharmaceutics and Biopharmaceutics 45 (1997), 113-136.